Why is Amerise BioScie falling/rising?

As of 07-Nov, Amerise Biosciences Ltd is experiencing a decline in its stock price, currently at 0.61, which reflects a decrease of 0.04 or 6.15%. The stock has underperformed its sector by 7.67% today, and it is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Additionally, there has been a significant drop in investor participation, with delivery volume falling by 29.59% compared to the 5-day average. Over the past year, the stock has seen a substantial decline of 44.55%, while its year-to-date performance shows a decrease of 49.59%. Unfortunately, there is no information available regarding positive or negative factors that could influence the stock's recent movement.
In the broader market context, Amerise Biosciences Ltd's short-term performance over the past week shows a decline of 3.17%, while the benchmark Sensex has only decreased by 0.86%. This indicates that the stock is underperforming relative to the broader market. Over the past month, the stock has also fallen by 3.17%, contrasting with the Sensex's gain of 1.57%. The significant underperformance in both short-term and long-term returns compared to the benchmark suggests that investor sentiment towards Amerise Biosciences Ltd is currently negative, contributing to the ongoing decline in its stock price.